[HTML][HTML] Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs

MF Mohamed, GK Hammac, L Guptill, MN Seleem - PloS one, 2014 - journals.plos.org
Staphylococcus pseudintermedius is a major cause of skin and soft tissue infections in
companion animals and has zoonotic potential. Additionally, methicillin-resistant S …

[HTML][HTML] Structure–Activity Study, Characterization, and Mechanism of Action of an Antimicrobial Peptoid D2 and Its d- and l-Peptide Analogues

I Greco, JE Hansen, B Jana, N Molchanova, A Oddo… - Molecules, 2019 - mdpi.com
Methicillin-resistant Staphylococcus pseudintermedius (MRSP) constitutes an emerging
health problem for companion animals in veterinary medicine. Therefore, discovery of novel …

[HTML][HTML] Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin …

I Greco, AP Emborg, B Jana, N Molchanova, A Oddo… - Scientific Reports, 2019 - nature.com
Integumentary infections like pyoderma represent the main reason for antimicrobial
prescription in dogs. Staphylococcus pseudintermedius and Pseudomonas aeruginosa are …

Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides

MF Mohamed, MI Hamed, A Panitch… - Antimicrobial agents …, 2014 - Am Soc Microbiol
The seriousness of microbial resistance combined with the lack of new antimicrobials has
increased interest in the development of antimicrobial peptides (AMPs) as novel …

[HTML][HTML] In Vitro/Vivo Mechanisms of Antibacterial Peptide NZ2114 against Staphylococcus pseudintermedius and Its Biofilms

S Zhang, N Yang, R Mao, Y Hao, D Teng, J Wang - Antibiotics, 2024 - mdpi.com
Staphylococcus pseudintermedius is an opportunistic pathogen commonly found in canines,
and has garnered escalating interest due to its potential for zoonotic transmission and …

In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant Staphylococcus aureus

Y Zhang, D Teng, X Wang, R Mao, X Cao, X Hu… - Applied microbiology …, 2015 - Springer
Currently, more antimicrobial drug candidates are urgently needed to combat the rise in
drug-resistance among pathogenic microbes. A new antimicrobial peptide, MP1102, a …

Anti-Staphylococcal and cytotoxic activities of the short anti-microbial peptide PVP

H Memariani, M Memariani, RM Robati, S Nasiri… - World Journal of …, 2020 - Springer
Over the past years, short anti-microbial peptides have drawn growing attention in the
research and trade literature because they are usually capable of killing a broad spectrum of …

Fluorinated antimicrobial lysine‐based peptidomimetics with activity against methicillin‐resistant Staphylococcus pseudintermedius

N Molchanova, PR Hansen, P Damborg… - Journal of Peptide …, 2018 - Wiley Online Library
Staphylococcus pseudintermedius is the predominant opportunistic pathogen in dogs
causing primarily integumentary infections such as pyoderma and otitis. The worldwide …

Cell-penetrating peptide and antibiotic combination therapy: a potential alternative to combat drug resistance in methicillin-resistant Staphylococcus aureus

HK Randhawa, A Gautam, M Sharma, R Bhatia… - Applied microbiology …, 2016 - Springer
The diverse pattern of resistance by methicillin-resistant Staphylococcus aureus (MRSA) is
the major obstacle in the treatment of its infections. The key reason of resistance is the poor …

[HTML][HTML] Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus

MF Mohamed, A Abdelkhalek, MN Seleem - Scientific reports, 2016 - nature.com
Methicillin-resistant Staphylococcus aureus (MRSA) infections present a serious challenge
because of the emergence of resistance to numerous conventional antibiotics. Due to their …